701-34-8 | 4-Bromobenzenesulfonamide

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$6.00	$5.00
10g	98%	in stock	$11.00	$8.00
500g	98%	in stock	$510.00	$357.00

Description

• Catalog Number: AC60471
• Chemical Name: 4-Bromobenzenesulfonamide
• CAS Number: 701-34-8
• Molecular Formula: C6H6BrNO2S
• Molecular Weight: 236.0863
• MDL Number: MFCD00051977
• SMILES: Brc1ccc(cc1)S(=O)(=O)N
• NSC Number: 31049

Computed Properties

• Complexity: 213
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 1
• XLogP3: 1.4

Literature

• Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.

  Journal of medicinal chemistry 20120412

• Correlation analyses on binding affinity of substituted benzenesulfonamides with carbonic anhydrase using ab initio MO calculations on their complex structures (II).

  Bioorganic & medicinal chemistry letters 20110101

• 2-Chloro-benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20090901

• o-Toluene-sulfonamide: a redetermination.

  Acta crystallographica. Section E, Structure reports online 20090901

• A structure-based approach to ligand discovery for 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase: a target for antimicrobial therapy.

  Journal of medicinal chemistry 20090423

• N-(4-Bromo-phenyl-sulfon-yl)-2,2,2-tri-methyl-acetamide.

  Acta crystallographica. Section E, Structure reports online 20080801

• alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.

  Bioorganic & medicinal chemistry 20070115

• Novel use of chemical shift in NMR as molecular descriptor: a first report on modeling carbonic anhydrase inhibitory activity and related parameters.

  Bioorganic & medicinal chemistry letters 20050215

• Topological modeling of lipophilicity, diuretic activity, and carbonic inhibition activity of benzene sulfonamides: a molecular connectivity approach.

  Bioorganic & medicinal chemistry letters 20041115

• Combining NMR and molecular modelling in a drug delivery context: investigation of the multi-mode inclusion of a new NPY-5 antagonist bromobenzenesulfonamide into beta-cyclodextrin.

  Bioorganic & medicinal chemistry 20040115

• Determination of ebrotidine metabolites in overlapping peaks from capillary zone electrophoresis using chemometric methods.

  Electrophoresis 20010101